DRAXIMAGE MDP-25 Drug Patent Profile
✉ Email this page to a colleague
When do Draximage Mdp-25 patents expire, and what generic alternatives are available?
Draximage Mdp-25 is a drug marketed by Jubilant and is included in one NDA.
The generic ingredient in DRAXIMAGE MDP-25 is technetium tc-99m medronate. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m medronate profile page.
Summary for DRAXIMAGE MDP-25
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DRAXIMAGE MDP-25 at DailyMed |
US Patents and Regulatory Information for DRAXIMAGE MDP-25
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jubilant | DRAXIMAGE MDP-25 | technetium tc-99m medronate | INJECTABLE;INJECTION | 018035-002 | Feb 27, 2004 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |